Overview
Alloimmune thrombocytopenia, particularly fetal and neonatal alloimmune thrombocytopenia (FNAIT), arises from maternal alloantibodies targeting paternal platelet antigens, leading to platelet destruction and thrombocytopenia in the fetus or neonate. 2Diagnosis
Key Diagnostic Criteria: Presence of maternal alloantibodies against fetal platelet antigens, typically HPA-3a.
Recommended Tests:
- MAIPA (Monoclonal Antibody-Specific Immobilization of Platelet Antigens) assay for detecting alloantibodies.
- Flow cytometry for assessing platelet antigen expression.
- Immunoprecipitation and immunoblotting for detailed antibody characterization.
Influence of Platelet Age and Storage: Fresh platelets are crucial for optimal detection; reactivity can diminish with storage exceeding 14 days. 2Management
First-Line Treatments:
- Intravenous Immunoglobulin (IVIG): Standard treatment to temporarily increase platelet count.
- Corticosteroids: Used in some cases to modulate immune response.
Adjunctive Treatments:
- Platelet Transfusion: Careful administration considering antibody reactivity and platelet age.
- Prevention Strategies: Avoidance of triggers that may exacerbate alloimmune responses.Special Populations
Pregnancy: FNAIT is a significant concern, requiring close monitoring and intervention to prevent neonatal thrombocytopenia. 2
Pediatrics: Neonates are particularly vulnerable; early diagnosis and management are critical to prevent hemorrhagic complications. 2Key Recommendations
Utilize fresh platelets and sensitive assays like MAIPA for accurate detection of HPA-3 alloantibodies in maternal sera. (Evidence: Moderate) 2
Employ IVIG as a first-line treatment to manage acute thrombocytopenia in affected neonates. (Evidence: Moderate) 2
Regular monitoring during pregnancy is essential for timely intervention in cases of suspected FNAIT. (Evidence: Expert opinion) 2References
1 Chen MZ, Wang ST, Chen DX, Peng W, Li ZX. Knowledge Mapping of Osteoimmunology:A Bibliometric Study. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2024. link
2 Socher I, Zwingel C, Santoso S, Kroll H. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Transfusion 2008. link